LGALS1 and chronic kidney disease: In comparison, the expression of galectin-1 was significantly increased with increasing CKD stage (CKD stage 1, 3 and 5; 3.0 ± 1.2, 10.1 ± 3.4 and 17.9 ± 6.4%, respectively), especially in the glomerular area with sclerotic change.